-
NCPC’s omitevirumab injection was approved
NCPC’s omitevirumab injection was approved for marketing North China Pharmaceuticals officially obtained the drug registration certificate of omitevirumab injection (Xunke®) issued by the State Drug Administration, marking the official approval of omitevirumab injection for marketing...Skaityti daugiau -
Sales Representative
Join NCPCVET and be part of a legacy where your growth is just as important as ours. We are passionate about and committed to providing customers with better and innovative solutions as well as high-quality services in a bid to help improve food safety and animal welfare. We know that when animal...Skaityti daugiau -
NCPCVET Pet Drugs Listed
The pet business division of NCPC was formally established in January 2018,with the strong research and development strength and advanced equipment of human medicine in North China Pharmaceutical Group, we will strive to build famous brands at home and abroad in the field of pet medicine, we...Skaityti daugiau -
Gamitromicinas sertifikavimas
Neseniai NCPCVET laimėjo naują narkotikų sertifikavimą nacionalinės antros klasės naujų veterinarinių su narkotikais "Gamitromicinas" ir "Gamitromicinas injekcija". Gamitromicinas yra romano pusiau sintetinis makrolidų grupės antibiotikas. Šiuo metu tailozinas ir tilmikozinas yra plačiai naudojamas kaip ma ...Skaityti daugiau
